THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: October 24, 2008 11:19 AM Friday;
Rod Welch
Millie 1st Neupgogen at Kaiser for 2nd cancer treatment 9th cycle UCSF
1...Summary/Objective
2...Neupogen Treatment at Kaiser Prescribed at UCSF for Clinical Trial
3...Schedule Neupogen Treatments Extended through August
4...Exercise Hiking Maintain Fitness Strengthen Immune System
5...Side Effects Neupogen Treatments Increase May Be Chemotherapy
..............
Click here to comment!
CONTACTS
SUBJECTS
Neupogen Side Effects Bone Pain Fatigue No Headache Suffered Today A
1503 -
1503 - ..
1504 - Summary/Objective
1505 -
150501 - Follow up ref SDS A2 0000. ref SDS A1 0000.
150502 -
150503 -
150504 -
150505 -
150506 -
150507 -
150509 - ..
1506 -
1507 -
1508 - Progress
1509 -
150901 - Neupogen Treatment at Kaiser Prescribed at UCSF for Clinical Trial
150902 -
150903 - Follow up ref SDS A2 9W9I, ref SDS A1 9W9I.
150904 -
150905 - Background on missing treatment at UCSF due to low blood counts, and
150906 - requirements for Neupogen are reported in the record on 081016.
150907 - ref SDS 99 OK67
150909 - ..
150910 - Case study on 060809 shows Millie has often received chemotherapy when
150911 - blood counts are below the standard for safe treatments, and on some
150912 - occassions has received Neupogen to increase blood counts. ref SDS 9
150913 - HV45
150915 - ..
150916 - Research on neutropenia was reported on 070301, ref SDS 10 O59H, when
150917 - Doctor Rugo was concerned about holding blood counts with weekly
150918 - Carboplatin treatments. ref SDS 10 VF6O
150920 - ..
150921 - Kaiser called this morning and changed the meeting today from 1230 to
150922 - 1100, because of a staff meeting.
150924 - ..
150925 - Florida was Millie's nurse today. She gave Millie 2 injections
150926 - required for prescription of treatment...
150927 -
150928 - Neupogen 480 mcg SQ on D2 3 3 carbo
150929 -
150930 - ...as shown in UCSF Chemotherapy Order on 080918, ref SDS 82 PWSY, and
150931 - ordered by primary care physician at Kaiser on 080609. ref SDS 38 L16I
150933 - ..
150934 - Prior instructions describe Kaiser protocol calls for 480 mcg be given
150935 - with 2 injections, discussed on 080801 ref SDS 58 9W9I, and originally
150936 - presented by Laura on 080628. ref SDS 43 Q74G
150937 -
150938 -
150939 -
150940 -
1510 -
SUBJECTS
Default Null Subject Account for Blank Record
1603 -
160401 - ..
160402 - Schedule Neupogen Treatments Extended through August
160403 -
160404 - Follow up ref SDS A2 WJ4O, ref SDS A1 WJ4O.
160405 -
160406 - Millie's schedule for was last updated on 081018. ref SDS A2 WJ4O
160407 -
160408 -
160409 -
1605 -
SUBJECTS
Default Null Subject Account for Blank Record
1703 -
170401 - ..
170402 - Exercise Hiking Maintain Fitness Strengthen Immune System
170403 -
170404 - Follow up ref SDS A4 3E4K, ref SDS A3 3E4K,.
170405 -
170406 - Millie did not got hiking today, because she has several meetings at
170407 - Kaiser to set up for starting treatment of the 5th relapse of IBC.
170409 - ..
170410 - Hiking will be reduced this coming week, because of meetings getting
170411 - setu for changing treatments. Millie is vacation for the next two
170412 - weeks.
170413 -
170414 - +- c = Carboplatin
170415 - +- e = Erbatex cetuximab
170416 - Time Pulse |
170417 - Location Miles Minutes Avg Max Chem Neupo Date
170418 - ----------------------------------------------------------------
170419 - Kaiser x 081024, ref SDS 0 3E4K
170420 - UCSF c 081023, ref SDS A5 V94O
170421 - Lafayette 5.50 90.6 115 141 081021, ref SDS A4 3E4K
170422 - Lafayette 5.50 90.6 115 141 081021, ref SDS A4 3E4K
170423 - Lafayette 5.50 90.4 110 128 081020, ref SDS A3 3E4K
170424 - Lafayette 5.50 90.1 115 154 081014, ref SDS 98 3E4K
170425 - Lafayette 5.50 92.7 115 138 081013, ref SDS 97 3E4K
170426 - Lafayette 8.25 146.4 180 224 081012, ref SDS 96 3E4K
170427 - Kaiser x 081011, ref SDS 95 3E4K
170428 - Lafayette 5.50 93.3 116 138 x 081010, ref SDS 94 3E4K
170429 - UCSF e 081009, ref SDS 93 V94O
170430 - Lafayette 5.50 92.1 113 137 081006, ref SDS 92 3E4K
170431 - Lafayette 2.75 48.5 110 136 x 081004, ref SDS 91 3E4K
170432 - Lafayette 5.50 98.2 117 136 x 081003, ref SDS 90 3E4K
170433 - UCSF c 081002, ref SDS 89 V94O
170434 - Lafayette 5.50 94.7 115 142 080929, ref SDS 88 3E4K
170435 - Lafayette 8.25 150.4 115 135 080928, ref SDS 88 3E4K
170436 - Kaiser x 080927, ref SDS 87 UZ7K
170437 - Lafayette 5.50 90.2 120 140 x 080926, ref SDS 86 3E4K
170438 - UCSF c 080925, ref SDS 85 V94O
170439 - Lafayette 5.50 92.3 116 138 080923, ref SDS 84 3E4K
170440 - Lafayette 5.50 98.4 112 134 080922, ref SDS 84 3E4K
170441 - Lafayette 5.50 98.2 114 137 080921, ref SDS 84 3E4K
170442 - Lafayette 5.50 101.6 110 133 x 080920, ref SDS 83 3E4K
170443 - Lafayette 5.50 89.3 115 144 x 080919, ref SDS 82 3E4K
170444 - UCSF c 080918, ref SDS 81 V94O
170445 - Lafayette 2.75 46.2 117 139 080916, ref SDS 82 3E4K
170446 - Lafayette 5.50 91.8 117 142 080915, ref SDS 80 3E4K
170447 - Clayton Safeway 3.00 62.4 98 118 080914, ref SDS 79 3E4K
170448 - Lafayette 8.25 129.7 123 147 x 080913, ref SDS 78 3E4K
170449 - Lafayette 5.50 88.4 118 146 x 080912, ref SDS 77 3E4K
170450 - UCSF c 080911, ref SDS 76 V94O
170451 - Lafayette 2.75 46.8 113 140 080909
170452 - Lafayette 5.50 89.2 117 143 080908
170453 - Lafayette 5.50 92.1 115 138 080907
170454 - Lafayette 2.75 45.3 120 144 x 080906, ref SDS 75 3E4K
170455 - Lafayette 2.75 56.8 93 120 x 080905, ref SDS 74 3E4K
170456 - UCSF c 080904, ref SDS 73 V94O
170457 - Lafayette 8.25 140.4 116 131 080903
170458 - Lafayette 5.50 94.9 115 134 080902
170459 - Kaiser x 080830
170460 - Kaiser x 080829
170461 - UCSF c 080828, ref SDS 70 V94O
170462 - Lafayette 5.50 93.6 120 137 080826
170463 - Lafayette 5.50 93.2 117 138 080825
170464 - Lafayette 5.50 93.2 123 136 x 080823
170465 - Lafayette 8.25 142.5 110 131 x 080822, ref SDS 68 3E4K
170466 - UCSF e 080821, ref SDS 67 V94O
170467 - Lafayette 5.50 94.7 115 137 080820
170468 - Lafayette 5.50 94.3 115 135 080819
170469 - Lafayette 8.25 141.7 118 134 080815
170470 - UCSF e 080814, ref SDS 65 V94O
170471 - Lafayette 5.50 93.8 120 136 080813
170472 - Lafayette 5.50 94.4 116 139 080812
170473 - Lafayette 5.50 94.2 119 133 080810
170474 - Lafayette 8.25 143.6 114 132 x 080809, ref SDS 62 3E4K
170475 - Lafayette 8.25 141.1 117 135 x 080808, ref SDS 61 3E4K
170476 - UCSF c 080807, ref SDS 60 V94O
170477 - Lafayette 8.25 143.7 115 132 080805
170478 - Concord 7.00 127.6 105 118 080804
170479 - Lafayette 8.25 143.2 112 134 080802
170480 - Lafayette 5.50 93.4 115 138 080801
170481 - Lafayette 5.50 92.2 118 140 080729
170482 - Lafayette 5.50 92.6 116 137 080728
170483 - Lafayette 8.25 142.6 114 134 080727
170484 - Lafayette 5.50 91.5 120 143 080726
170485 - Lafayette 8.25 140.8 117 135 080725
170486 - Lafayette 5.50 91.8 122 141 080723
170487 - Lafayette 5.50 91.3 120 139 080722
170488 - Lafayette 8.25 143.3 115 133 080720
170489 - Lafayette 5.50 90.7 125 144 080719
170490 - Lafayette 5.50 92.4 123 142 080716
170491 - Lafayette 2.25 46.8 116 137 080715
170492 - Lafayette 8.25 141.8 116 136 080712
170493 - Lafayette 5.50 92.9 116 139 080711
170494 - Lafayette 8.25 143.3 113 137 080704
170495 - Lafayette 5.50 90.2 121 147 080630
170496 - Lafayette 8.25 142.4 116 138 080628
170497 - Lafayette 5.50 91.4 118 138 080625
170498 - Lafayette 2.25 47.9 116 136 080623
170499 - Lafayette 5.50 94.2 112 138 080622
170500 - Lafayette 5.50 94.7 115 133 080621
170501 - Lafayette 2.25 48.3 110 129 080620
170502 - Mt Diablo 7.00 129.4 130 153 080616
170503 - Lafayette 5.50 90.8 120 146 080615
170504 - Lafayette 5.50 91.3 124 144 080614
170505 - Lafayette 5.50 89.7 122 143 080613
170506 - Lafayette 2.76 45.8 120 147 080611
170507 - Lafayette 5.50 90.5 123 145 080609
170508 - Lafayette 5.50 92.7 115 138 080607
170509 - Lafayette 5.50 94.2 118 139 080602
170510 - Lafayette 5.50 96.2 110 202 080507, ref SDS 30 WO8M
170511 -
170512 -
170513 -
170514 -
1706 -
SUBJECTS
Default Null Subject Account for Blank Record
1803 -
180401 - ..
180402 - Side Effects Neupogen Treatments Increase May Be Chemotherapy
180403 -
180404 - Follow up ref SDS A2 SB8I, ref SDS A1 SB8I.
180405 -
180406 - Research on Neupogen side effects was reported on 080629. ref SDS 44
180407 - RQ9I Previous case study on Neupogen side effects listed on 081002.
180408 - ref SDS 86 SB8I
180410 - ..
180411 - She had a long day, going to Kaiser for Neupogen, then to a meeting
180412 - for a biopsy that turned out to be deferred. ref SDS A6 G15K She then
180413 - had a meeting with the primary care physician to review planning at
180414 - UCSF for starting a new treatment to recover from the 5th relapse of
180415 - IBC. ref SDS A7 0001 There were then extended discussions with the
180416 - CT department about doing a test using the Power Port.
180418 - ..
180419 - Despite all of this emotional activity, Millie did not complain of
180420 - specific bone pain, fatigue, nor headache, which are side effects of
180421 - chemotherapy.
180423 - ..
180424 - Millie last reported side effects on 081018 experiencing bone pain,
180425 - headache, and fatigue associated with Neupogen and chemotherapy.
180426 - ref SDS A2 Y17L
180428 - ..
180429 - Side effects of Neupogen may be increasing, reported on...
180430 -
180431 - 081018................, ref SDS A2 Y17L
180432 - 081011................, ref SDS 95 FL4H
180433 - 081010................, ref SDS 94 SB8I
180434 - 081006................, ref SDS 92 3E4K
180435 - 081004................, ref SDS 91 Y17L
180436 - 081002................, ref SDS 89 Y17L
180437 - 080930................, ref SDS 88 Y17L
180438 - 080923................, ref SDS 84 K16F
180439 - 080915................, ref SDS 80 9W9I
180440 - 080810................, ref SDS 63 9W9I
180441 - 080803................, ref SDS 59 9W9I
180442 - 080726................, ref SDS 56 9W9I
180443 - 080721................, ref SDS 54 9W9I
180444 - 080713................, ref SDS 48 RM94
180445 - 080629................, ref SDS 43 6Q5J
180446 - 080628................, ref SDS 41 6Q5J
180447 -
180448 -
180449 -
180450 -
180451 -
180452 -
180453 -
1805 -